Skip to Main content Skip to Navigation
Journal articles

Silibinin and related compounds are direct inhibitors of hepatitis C virus RNA-dependent RNA polymerase.

Abstract : BACKGROUND & AIMS: Silymarin is a mixture of flavonolignans extracted from the milk thistle. Silymarin contains several molecules, including silibinin A, silibinin B, isosilibinin A, isosilibinin B, silicristin, and silidianin. Intravenous infusion of silibinin induces dose-dependent reduction of hepatitis C virus (HCV) RNA levels. The aim of this study was to test the principal isomers contained in silymarin preparations for their ability to inhibit HCV enzymatic functions and replication in different models. METHODS: The inhibitory activity of silymarin components was tested in HCV RNA-dependent RNA polymerase and NS3/4A protease enzyme assays. Their ability to inhibit replication of an HCV genotype 1b replicon model and the JFH1 infectious HCV model in cell culture was also studied. RESULTS: Silibinin A, silibinin B, their water-soluble dihydrogen succinate forms and Legalon SIL, a commercially available intravenous preparation of silibinin, inhibited HCV RNA-dependent RNA polymerase function, with inhibitory concentrations 50% of the order of 75-100 microM. Silibinin A and silibinin B also inhibited HCV genotype 1b replicon replication and HCV genotype 2a strain JFH1 replication in cell culture. None of these compounds inhibited HCV protease function. CONCLUSIONS: Silibinin A and silibinin B, as well as Legalon SIL, inhibit HCV replicon and JFH1 replication in cell culture. This effect is at least partly explained by the ability of these compounds to inhibit HCV RNA-dependent RNA polymerase activity. Our results provide a basis for the optimization and subsequent development of members of the Flavonoid family as specific HCV antivirals.
Document type :
Journal articles
Complete list of metadata

Cited literature [13 references]  Display  Hide  Download
Contributor : Georges Guellaen Connect in order to contact the contributor
Submitted on : Monday, March 22, 2010 - 1:08:38 PM
Last modification on : Wednesday, March 23, 2022 - 5:20:02 PM
Long-term archiving on: : Monday, June 28, 2010 - 4:16:54 PM




Abdelhakim Ahmed-Belkacem, Nazim Ahnou, Laetitia Barbotte, Czeslaw Wychowski, Coralie Pallier, et al.. Silibinin and related compounds are direct inhibitors of hepatitis C virus RNA-dependent RNA polymerase.. Gastroenterology, WB Saunders, 2010, 138 (3), pp.1112-22. ⟨10.1053/j.gastro.2009.11.053⟩. ⟨inserm-00465965⟩



Record views


Files downloads